Antithrombin plus alpha–1 protease inhibitor does not affect pulmonary inflammation and coagulation in a ‘double-hit’ lung injury model
J. Juschten (Amsterdam, Netherlands), S. Ingelse (Amsterdam, Netherlands), M. Maas (Amsterdam, Netherlands), A. Girbes (Amsterdam, Netherlands), N. Juffermans (Amsterdam, Netherlands), M. Schultz (Bangkok, Thailand), P. Tuinman (Amsterdam, Netherlands)
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Session: Preclinical and clinical studies of critical illness
Session type: Thematic Poster
Number: 2312
Disease area: Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Juschten (Amsterdam, Netherlands), S. Ingelse (Amsterdam, Netherlands), M. Maas (Amsterdam, Netherlands), A. Girbes (Amsterdam, Netherlands), N. Juffermans (Amsterdam, Netherlands), M. Schultz (Bangkok, Thailand), P. Tuinman (Amsterdam, Netherlands). Antithrombin plus alpha–1 protease inhibitor does not affect pulmonary inflammation and coagulation in a ‘double-hit’ lung injury model. 2312
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 461s Year: 2005
Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation Source: Eur Respir J 2007; 30: 423-428 Year: 2007
A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012
Increased intraalveolar levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with interstitial lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 586s Year: 2002
Treatment with proteinase inhibitor, BbCI, modulates inflammatory response, mechanic alterations, and remodeling on elastase-induced emphysema in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury Source: Eur Respir J 2008; 31: 633-644 Year: 2008
Role of thrombin-activatable fibrinolysis inhibitor in lipopolysaccharide-induced acute lung injury Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury Source: Eur Respir J 2003; 22: 20-27 Year: 2003
Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008
Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008
Effect of proteinase inhibitor from crataeva tapia (cratabl) in distal lung mechanical, inflammatory and remodeling alterations induced by elastase in mice Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
Plant proteinase inhibitor from enterolobium contortisiliquum (EcTI ) attenuates elastase-induced pulmonary inflammatory and remodeling alterations in mice Source: Annual Congress 2011 - Recent developments in COPD Year: 2011
Intraalveolar levels of tenascin C and thrombin-activatable fibrinolysis inhibitor in interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003
Effects of phosphodiesterase inhibitors on the lung functions in a saline lavage-induced model of acute lung injury Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017
Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018
Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Plant proteinase inhibitor from Enterolobium contortisiliquum (EcTI ) attenuates elastase-induced pulmonary inflammatory, remodeling and mechanical alterations in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012